Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome

被引:31
|
作者
Dillon, SC [1 ]
Taylor, GM [1 ]
Shah, V [1 ]
机构
[1] Great Ormond St Hosp Children NHS Trust, Renal Unit, London WC1N 3JH, England
关键词
nephrotic syndrome; minimal change nephrotic syndrome; focal segmental glomerulosclerosis; N-acetyl-beta-D-glucosaminidase; retinol-binding protein;
D O I
10.1007/s004670050519
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and retinol-binding protein (RBP), sensitive markers of renal tubular damage and dysfunction respectively, were evaluated in paired remission and relapse urine samples from 16 patients (median age 12 years), with minimal change nephrotic syndrome (MCNS), in single samples from 5 nephrotic patients (median age 12 years) with focal segmental glomerulosclerosis (FSGS) and in 183 normal controls aged 2-16 years. The NAG and REP data were expressed as a ratio over urinary creatinine (Cr). The NAG/Cr and RBP/Cr geometric means (ranges) for normal subjects were 11.1(3.4-35.5) mu mol 2-methoxy-4-(2'-nitrovinyl)-phenol (MNP)/h per mmol and 3.1 (0.3-38.8) mu g/mmol, respectively. The NAG/Cr data revealed a weak negative correlation with age in normal children, whereas RBP/Cr was independent of age. RBP/Cr and NAG/Cr in MCNS in remission were the same as in controls. In MCNS in relapse, NAG/Cr was significantly elevated (P=<0.001), while in FSGS both RBP/Cr and NAG/Cr were significantly raised (P=<0.001 and P<0.008, respectively). These findings suggest that elevated NAG/Cr may be an indicator of relapse in both MCNS and FSGS and elevated RBP/Cr may allow differentiation between the two.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 50 条
  • [1] Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome
    Susannah C. Dillon
    G. Michael Taylor
    Vanita Shah
    Pediatric Nephrology, 1998, 12 : 643 - 647
  • [2] Urinary retinol-binding protein as a prognostic marker in the treatment of nephrotic syndrome
    Kirsztajn, GM
    Nishida, SK
    Silva, MS
    Ajzen, H
    Pereira, AB
    NEPHRON, 2000, 86 (02) : 109 - 114
  • [3] Clinical value of urinary retinol-binding protein in ascites due to cirrhosis
    Xia, Yujing
    Li, Jingjing
    Li, Sainan
    Liu, Tong
    Zhou, Yuqing
    Yin, Qin
    Wang, Jianrong
    Lu, Wenxia
    Zhang, Rong
    Zheng, Yuanyuan
    Wang, Fan
    Lu, Jie
    Chen, Kan
    Dai, Weiqi
    Zhou, Yingqun
    Guo, Chuanyong
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2017, 14 (05) : 5228 - 5234
  • [4] URINARY ALBUMIN AND RETINOL-BINDING PROTEIN IN DIABETES
    BEETHAM, R
    SILVER, A
    DAWNAY, A
    CLINICAL CHEMISTRY, 1987, 33 (05) : 713 - 713
  • [5] PREDICTION OF STEROID RESPONSIVENESS IN THE IDIOPATHIC NEPHROTIC SYNDROME USING URINARY RETINOL-BINDING PROTEIN AND BETA-2-MICROGLOBULIN
    SESSO, R
    SANTOS, AP
    NISHIDA, SK
    KLAG, MJ
    CARVALHAES, JT
    AJZEN, H
    RAMOS, OL
    PEREIRA, AB
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (11) : 905 - 909
  • [6] Urinary retinol-binding protein as a prognostic marker in glomerulopathies
    Kirsztajn, GM
    Nishida, SK
    Silva, MS
    Ajzen, H
    Moura, LA
    Pereira, AB
    NEPHRON, 2002, 90 (04) : 424 - 431
  • [7] URINARY LEVELS OF RETINOL-BINDING PROTEIN (URRBP) IN GLOMERULOPATHIES
    KIRSZTAJN, GM
    NISHIDA, SK
    SILVA, MS
    LOPES, LMV
    MONTEIRO, MCA
    VAISBICH, MH
    AJZEN, H
    PEREIRA, AB
    KIDNEY INTERNATIONAL, 1994, 46 (06) : 1750 - 1750
  • [8] RETINOL-BINDING PROTEIN
    MUTO, Y
    SEIKAGAKU, 1977, 49 (09): : 1019 - 1022
  • [9] THE RETINOL-BINDING PROTEIN
    RASK, L
    ANUNDI, H
    BOHME, J
    ERIKSSON, U
    FREDRIKSSON, A
    NILSSON, SF
    RONNE, H
    VAHLQUIST, A
    PETERSON, PA
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1980, 40 : 45 - 61
  • [10] Expression of retinol-binding protein and cellular retinol-binding protein in the bovine ovary
    Brown, JA
    Eberhardt, DM
    Schrick, FN
    Roberts, MP
    Godkin, JD
    MOLECULAR REPRODUCTION AND DEVELOPMENT, 2003, 64 (03) : 261 - 269